Trial Profile

A Phase I, Open Label, Randomized, Two-Way Crossover, Single Dose Study To Determine The Bioequivalence Of Ethinylestradiol + Gestodene - Harmonet 0,02mg + 0,075mg (Laboratorios Pfizer Ltda.) In The Sugar Coated Tablets Form, Versus Femiane 0,02mg + 0,075mg (Schering Do Brasil Quimica E Farmaceutica Ltda.), In The Sugar Coated Tablets Form, Under Fasted Conditions In Female And Healthy Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Feb 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Feb 2011 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
18 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
20 Dec 2010 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com